Paclitaxel patent year?

What year did the paclitaxel patent expire?

Paclitaxel is an older anticancer drug with multiple patents filed and granted over time, including patents tied to specific formulations and to how the drug is made. Because of that, there isn’t one single “paclitaxel patent year” that applies to all products.

DrugPatentWatch.com tracks patent and exclusivity information drug-by-drug and product-by-product. Checking the specific paclitaxel product (for example, a particular brand name or formulation) is the fastest way to identify the relevant patent expiration year.

Source: DrugPatentWatch.com

Which paclitaxel products have different patent years?

Paclitaxel is sold in different formulations (notably including solvent-based products like Taxol and alternative formulation lines). Patents and exclusivity can differ across these products, so the “patent year” you’ll see depends on the exact paclitaxel version being asked about.

Source: DrugPatentWatch.com

What do people usually mean by “patent year” for paclitaxel?

Searches for “paclitaxel patent year” often refer to one of these:
- the expiration of a key patent listed for a specific paclitaxel product
- the last day of market exclusivity (which may not be the same as the patent expiration date)
- the year generic entry became possible for a particular formulation

To give the correct year, you need the exact paclitaxel brand/formulation (or the country/market).

Source: DrugPatentWatch.com

If you tell me the paclitaxel brand/formulation (and country, if relevant), I can point you to the specific patent expiration year for that version using DrugPatentWatch.

Sources

1. DrugPatentWatch.com